Latest news
Merck's (MRK.US) oral anti-HIV drug applies for market approval in China - BitgetBitget · Fri, 07 Aug 2026 05:57:54 GMTDriven by both the life sciences and electronics sectors, Merck Germany surpassed Q2 expectations and raised its full-year profit guidance. - BitgetBitget · Wed, 05 Aug 2026 22:46:03 GMTMERCK & CO INC : JP MORGAN RAISES TARGET PRICE TO $150 FROM $140 - BitgetBitget · Wed, 05 Aug 2026 07:13:59 GMTMerck 2Q FY26 net loss widens to $1.34 billion; sales rise 5% to $16.61 billion - BitgetBitget · Tue, 04 Aug 2026 23:01:16 GMTMERCK & CO INC : GUGGENHEIM RAISES TARGET PRICE TO $146 FROM $145 - BitgetBitget · Tue, 04 Aug 2026 19:24:09 GMTMerck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street? - BitgetBitget · Tue, 04 Aug 2026 11:44:26 GMTEarnings Preview | Pfizer (PFE.US) and Merck (MRK.US) Announce Results on the Same Day: As Patent Cliff Meets New Growth Engines, the Pharmaceutical Industry Faces a Valuation Test - BitgetBitget · Tue, 04 Aug 2026 00:31:07 GMT